Surmodics to Webcast First Quarter 2016 Earnings Conference Call on January 28
Webcast is Live at 7:30 a.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jan. 21, 2016--
Surmodics, Inc. (Nasdaq:SRDX), a leading provider of medical device and
in vitro diagnostic technologies to the healthcare industry, announced
today that it will host a live webcast of its first quarter fiscal 2016
conference call on Thursday, January 28, at 7:30 a.m. CT (8:30 a.m. ET).
The Company will issue an earnings news release earlier that morning.
Gary Maharaj, president and chief executive officer, and Andy LaFrence,
vice president of finance and chief financial officer, will recap the
first quarter 2016 financial results and accomplishments. To access the
webcast, go to the investor relations portion of the Company’s website
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 10:30 a.m. CT on
Thursday, January 28, until 10:30 a.m. CT on Thursday, February 4, and
can be accessed by dialing 888-203-1112 and entering conference call ID
passcode 167645. In addition, the conference call audio and transcript
will be archived on the Company’s website following the call.
About Surmodics, Inc.
Surmodics partners with the world's
leading and emerging medical device, diagnostic and life sciences
companies to develop and commercialize innovative products designed to
improve lives by enabling the detection and treatment of disease.
Surmodics’ mission is to be a trusted partner to its customers by
providing the most advanced surface modification technologies and in
vitro diagnostic chemical components that help enhance the
well-being of patients. The company’s core offerings include surface
modification coating technologies that impart lubricity, prohealing and
biocompatibility characteristics and components for in vitro
diagnostic test kits and microarrays. Surmodics’ strategy is to build on
the product and technical leadership within these fields, and expand the
core offerings to generate opportunities for longer term sustained
growth. Surmodics is headquartered in Eden Prairie, Minnesota. For more
information about the Company, visit www.surmodics.com.
The content of Surmodics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160121005229/en/
Source: Surmodics, Inc.
Andy LaFrence, 952-500-7000